In vitro induction of CYP1A1-associated activities in human and rodent cell lines by commercial and tissue-extracted halogenated aromatic hydrocarbons

被引:17
作者
Vamvakas, A [1 ]
Keller, J [1 ]
Dufresne, M [1 ]
机构
[1] UNIV WINDSOR, DEPT BIOL SCI, WINDSOR, ON N9B 3P4, CANADA
关键词
HAHs; AHH/EROD activities; cells;
D O I
10.1002/etc.5620150602
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Despite reports of species-specific differences, the rat cell line H4IIE continues to be used to assess the toxicity of many halogenated aromatic hydrocarbon (HAH) contaminants for diverse populations using an approach that relates aryl hydrocarbon (Ah) receptor-mediated responses by HAHs to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). To assess the relevance of H4IIE for human populations, we examined levels of aryl hydrocarbon hydroxylase (AHH) and ethyoxyresorufin O-deethylase (EROD) activities in H4IIE rat liver, HepG2 human liver, and MCF-7 human breast cells treated with TCDD and three coplanar polychlorinated biphenyl (PCB) congeners (77, 126, 169), alone or in combination, and to fractions extracted from the muscle tissue of Lake Ontario rainbow trout (Oncorhynchus ml kiss). H4IIB was generally more sensitive to all HAH treatments. Both AHH and EROD activities were induced in all cells treated with TCDD and PCB-126, alone or combined with each other. In contrast, neither activity was induced in human cells treated with PCB-77 or PCB-169. For inducing concentrations of PCBs, the induction response in all cell lines treated with 5 nM TCDD-PCB mixtures was generally nonadditive; only the response in H4IIE treated with 10(-3) nM TCDD-PCB mixtures was generally additive. With tissue extracts, induction was restricted to H4IIE cells treated with TCDD/PCB-or organochloride pesticide-containing fractions. Our initial results suggest that differences in the properties of each HAH or in levels of Ah receptor in each cell line are not likely to underlie the significant differences in the murine/human induction responses.
引用
收藏
页码:814 / 823
页数:10
相关论文
共 42 条
[1]   TOXIC EQUIVALENCY FACTORS FOR DIOXIN-LIKE PCBS - REPORT ON A WHO-ECEH AND IPCS CONSULTATION, DECEMBER 1993 [J].
AHLBORG, UG ;
BECKING, GC ;
BIRNBAUM, LS ;
BROUWER, A ;
DERKS, HJGM ;
FEELEY, M ;
GOLOR, G ;
HANBERG, A ;
LARSEN, JC ;
LIEM, AKD ;
SAFE, SH ;
SCHLATTER, C ;
WAERN, F ;
YOUNES, M ;
YRJANHEIKKI, E .
CHEMOSPHERE, 1994, 28 (06) :1049-1067
[2]   BINDING OF POLYCHLORINATED-BIPHENYLS CLASSIFIED AS EITHER PHENOBARBITONE-TYPE, 3-METHYLCHOLANTHRENE-TYPE OR MIXED-TYPE INDUCERS TO CYTOSOLIC AH RECEPTOR [J].
BANDIERA, S ;
SAFE, S ;
OKEY, AB .
CHEMICO-BIOLOGICAL INTERACTIONS, 1982, 39 (03) :259-277
[3]   SPECIES-SPECIFIC BINDING OF TRANSFORMED AH RECEPTOR TO A DIOXIN RESPONSIVE TRANSCRIPTIONAL ENHANCER [J].
BANK, PA ;
YAO, EF ;
PHELPS, CL ;
HARPER, PA ;
DENISON, MS .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1992, 228 (2-3) :85-94
[4]   AROCLOR-1254 AS A 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN ANTAGONIST - EFFECTS ON ENZYME-INDUCTION AND IMMUNOTOXICITY [J].
BANNISTER, R ;
DAVIS, D ;
ZACHAREWSKI, T ;
TIZARD, I ;
SAFE, S .
TOXICOLOGY, 1987, 46 (01) :29-42
[5]   SYNERGISTIC INTERACTIONS OF 2,3,7,8-TCDD AND 2,2',4,4',5,5'-HEXACHLOROBIPHENYL IN C57BL/6J AND DBA/2J MICE - ROLE OF THE AH RECEPTOR [J].
BANNISTER, R ;
SAFE, S .
TOXICOLOGY, 1987, 44 (02) :159-169
[6]   2,2',4,4',5,5'-HEXACHLOROBIPHENYL AS A 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN ANTAGONIST IN C57BL/6J MICE [J].
BIEGEL, L ;
HARRIS, M ;
DAVIS, D ;
ROSENGREN, R ;
SAFE, L ;
SAFE, S .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 97 (03) :561-571
[7]   ASSESSMENT OF THE EROD INDUCING POTENCY OF 11 2,3,7,8-SUBSTITUTED PCDD/FS AND 3 COPLANAR PCBS IN THE CHICK-EMBRYO [J].
BOSVELD, BATC ;
VANDENBERG, M ;
THEELEN, RMC .
CHEMOSPHERE, 1992, 25 (7-10) :911-916
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
BRANDT I, 1985, DRUG METAB DISPOS, V13, P490
[10]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF A RAT-LIVER POLYCHLORINATED BIPHENYL (PCB) BINDING-PROTEIN [J].
BRUNDL, A ;
BUFF, K .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (04) :885-891